Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CStone Pharmaceuticals
  6. News
  7. Summary
    2616   KYG2588M1006

CSTONE PHARMACEUTICALS

(2616)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CStone Pharmaceuticals : Pharma Presents Clinical Trial Data at Oncology Conference; Shares Slip 3%

07/08/2021 | 02:10am EDT


ę MT Newswires 2021
All news about CSTONE PHARMACEUTICALS
09/19CSTONE PHARMACEUTICALS' : Investigational Cancer Treatment Shows Potential in Ph..
MT
09/17EQRx and its Partner CStone Pharmaceuticals Announce Presentation of Phase 3 ..
CI
09/17CStone Pharmaceuticals Will Present Registrational Clinical Study Data of Sug..
CI
09/16CSTONE PHARMACEUTICALS : to Present Phase 3 Trial Data of Non-Small Cell Lung Ca..
MT
09/15CSTONE PHARMACEUTICALS : received China NMPA IND approval for CS2006/NM21-1480, ..
AQ
09/14CSTONE PHARMACEUTICALS : Wins Chinese Regulators' OK to Start Clinical Trial of ..
MT
09/14CStone Pharmaceuticals Receives China NMPA IND Approval for CS2006/NM21-1480,..
CI
09/13CSTONE PHARMACEUTICALS : Investigational Antibody Trims Disease Progression, Dea..
MT
09/13Cstone Pharmaceuticals Presents Updated Data from Registrational Clinical Stu..
CI
09/09BLUEPRINT MEDICINES : CStone presents registrational bridging study data for GAV..
AQ
More news
Financials
Sales 2021 271 M 41,9 M 41,9 M
Net income 2021 -1 808 M -280 M -280 M
Net cash 2021 1 655 M 256 M 256 M
P/E ratio 2021 -7,47x
Yield 2021 -
Capitalization 11 845 M 1 832 M 1 832 M
EV / Sales 2021 37,6x
EV / Sales 2022 8,16x
Nbr of Employees 573
Free-Float 75,1%
Chart CSTONE PHARMACEUTICALS
Duration : Period :
CStone Pharmaceuticals Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSTONE PHARMACEUTICALS
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 10,24 CNY
Average target price 14,92 CNY
Spread / Average Target 45,8%
EPS Revisions
Managers and Directors
Ning Jun Jiang Chairman & Chief Executive Officer
Jian Xin Yang Chief Medical Officer & Senior Vice President
Xin Zhong Wang Chief Scientific Officer & Senior Vice President
Ting Yuk Wu Independent Non-Executive Director
Hong Bin Sun Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSTONE PHARMACEUTICALS22.22%1 832
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
REGENERON PHARMACEUTICALS34.93%67 775
WUXI APPTEC CO., LTD.35.75%60 418
VERTEX PHARMACEUTICALS-20.33%48 850